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Abstract Male C57BL/6 mice were fed diets supple-
mented with either b-carotene (BC) or lycopene (LY) that
were formulated for human consumption. Four weeks of
dietary supplementations results in plasma and lung
carotenoid (CAR) concentrations that approximated the
levels detected in humans. Bioactivity of the CARs was
determined by assaying their effects on the activity of the
lung transcriptome (*8,500 mRNAs). Both CARs acti-
vated the cytochrome P450 1A1 gene but only BC induced
the retinol dehydrogenase gene. The contrasting effects of
the two CARs on the lung transcriptome were further
uncovered in mice exposed to cigarette smoke (CS) for
3 days; only LY activated *50 genes detected in the lungs
of CS-exposed mice. These genes encoded inﬂammatory-
immune proteins. Our data suggest that mice offer a viable
in vivo model for studying bioactivities of dietary CARs
and their modulatory effects on lung genomic expression in
both health and after exposure to CS toxicants.
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Introduction
Many epidemiologic studies have suggested an ameliorat-
ing role for carotenoids (CARs) and other dietary
antioxidant micronutrients in cigarette smoke (CS)-induced
diseases including lung cancer [46]. A recent study of
1,194 French subjects suggested that b-carotene (BC)
protects against the decline in forced expiration volume
(FEV1) over an 8-year period in the general population and
that BC and vitamin E are protective against lung function
loss in heavy smokers [19]. Paradoxically, results from the
a-tocopherol, BC cancer prevention (ATBC) study, and the
BC and retinol efﬁcacy trial (CARET), two large investi-
gations that focused on disease chemoprevention with
nutritional supplements, suggested that smokers should
avoid high-dose BC supplements because of an increased
risk of lung cancer (e.g., 18 and 28% more lung cancers,
respectively) [54].
These paradoxical and unexpected data have stimulated
a number of in vivo studies to seek better understanding
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CARs could inﬂuence CS-induced lung pathobiology [18,
32, 35, 37, 38, 40, 41, 51, 56, 57, 61, 73, 75]. High doses
of BC were shown to increase the activities of cytochrome
P450s (CYPs) in rat lungs [57]. In the A/J mouse model
of CS-induced lung tumorogenesis, dietary BC supple-
mentation augmented lung BC concentrations but had no
effect on lung tumors induced by either whole CS [51]o r
gas-phase of CS [75]. In a similar model, BC supple-
mentation had no effect on CS carcinogen 4-(N-methyl-N-
nitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tu-
morogenesis [18].
Studies in ferrets have made important contributions in
deciphering the in vivo effects of CARs, CS and their
biological interactions [61]. In ferrets exposed to CS,
accelerated levels of lung cell proliferation and squamous
metaplasia were found in animals fed high doses of BC.
This study suggested that diminished retinoid signaling
pathways could represent a contributing mechanism related
to the increased tumor incidence seen in human smokers
[41]. Importantly, these investigators have also presented
evidence that the beneﬁcial and/or detrimental effects of
BC supplementation could be related to the doses of BC
administered [40, 41]. They have also shown that both low-
and high-dose lycopene (LY) supplementations substan-
tially inhibited CS-induced lung tissue squamous
metaplasia and proliferating cellular nuclear antigen
(PCNA) expression in ferrets [37], extending earlier
observations that LY administration appears to decrease
some markers of CS-induced lung bimolecular damages
[1].
In a recent study A/J mice fed varying concentrations of
BC were exposed to CS [32]. These investigators docu-
mented CS-induced effects on lung pathways related to
drug metabolism, oxidative stress, inﬂammation, matrix
degradation and apoptosis and demonstrated that BC itself
had minimal changes in lung gene expression, but it
decreased CS-related induction of inﬂammatory pathways.
These investigators concluded that BC effects on CS-
induced lung genomic proﬁles were negligible.
In the present study, we have explored CAR effects on
the lung transcriptome of C57BL/6 mice and compared
these effects with those in CAR (BC or LY) fed mice
exposed to CS using a somewhat similar CAR adminis-
tration and CS exposure strategy that was used previously
in A/J mice [51, 76]. Although C57BL/6 mice have been
less frequently used to study CS-related lung tumorogen-
esis [47, 76] and mice present a complex and somewhat
different in vivo CAR digestion, absorption and metabo-
lism proﬁles compared to humans [33], a rich array of
genetically engineered mice on C57BL6 genetic back-
ground are available for the study of nutrient-
environmental interactions in this mouse strain.
Methods
Protocols for humane treatment and utilization of mice
described in this study were approved by the Institutional
Animal Care and Use Committee of the University of
California, Davis.
Diets and mice
The basal diet was the AIN-93G rodent diet which is opti-
mized for rodent growth and health, and lacks added BC or
LY [36]. The AIN-93G diet was supplemented with gelatin
beadlets without CAR or gelatin beadlets with a crystalline
form of synthetic CAR. The beadlets themselves consist of
a starch-coated matrix of gelatin and sucrose stabilized with
small amounts of tocopherol, sodium ascorbate and ascor-
byl palmitate with tricalcium phosphate (BASF website).
Gelatin beadlets contained either 100 g BC or 100 g LY
(*77% all trans- and 23% total cis isomers) or no added
CAR/kg gelatin beadlets provided by BASF (Ballerup,
Denmark) and were developed for human consumption
[83]. The ﬁnal pelleted diets were prepared by DYETS,
Bethleham, PA. These diets contained 5 g of beadlets/kg
diet. The two CAR containing diets thus contained 0.5 g of
CAR/kg diet, a supplementation several-fold higher than
that used in human studies [54] but necessitated because of
the poor systemic deliveries of ingested CARs in rodents
[33]. It is likely that the pelleting process itself along with
the chamber CS exposures affected the stability of the
added BC and LY, causing some isomerization and oxida-
tion of at least a portion of the two CARs.
Preliminary studies of dose ranging protocol
for CAR administration
Male C57BL/6 mice (6 week old, 20–25 g) were obtained
from Charles River Laboratories (Wilmington, MA).
Twenty-four mice (6 groups of 4 mice per group) received
the basal AIN-93 G rodent unsupplemented diet. They were
housed in groups of 4 in polycarbonate cages with free
access to tap water and diet. All mice received the basal diet
for 2 weeks, reaching baseline low CAR concentrations in
plasma and tissues. After 2 weeks of this acclimatization
period, mice were subsequently fed with diets containing
either 0.5 g BC/kg diet or 0.5 g LY/kg diet or the unsup-
plemented basal diet for 1, 2, and 4 weeks. At 1, 2, or
4 weeks mice were sacriﬁced and plasma and lung tissue
were collected for analysis utilizing previously described
HPLC methodologies [51, 52]. As depicted in Fig. 1,
plasma and lung tissue BC peaked at 1 week, whereas LY
levels remained more stable but were higher than BC levels
at 4 weeks. The noted discrepancy in plasma and lung CAR
levels with constant oral intakes is most likely secondary to
24 Genes Nutr (2009) 4:23–39
123differences in BC/LY cleavages by 150,1 5 0 and 90,1 0 0
monooxygenases, different BC/LY substrate and/or
metabolite inductions of these metabolizing enzymes, and/
or other less clariﬁed biotransformations of the two CARs
[24]. We empirically selected the 4-week feeding regimens
for all the subsequent experiments designed to characterize
CAR effects on global lung genomic responses at two
widely divergent lung CAR concentrations, albeit with the
realization that plasma CAR levels only reached low human
levels for the two CARs [29, 63].
Experimental protocol
Twenty-four mice were randomly assigned to one of three
groups of eight mice. Each group was allowed to feed on
either a basal diet or the BC or LY-supplemented diets as in
the preliminary studies after receiving the basal diet for
2 weeks to allow mice to acclimatize to the diet containing
the gelatin beadlets without added CARs. After 2 weeks
the diets were changed to either the BC-supplemented diet
(0.5 g BC/kg diet), the LY-supplemented diet (0.5 g LY/kg
diet) or the basal diet lacking added CARs for four addi-
tional weeks. While continuing on the three assigned diets,
four mice in each dietary group were then exposed to either
CS or ﬁltered air for three additional days. Body weight
was measured before and after exposure to ﬁltered air or
CS. Mice had unrestricted access to water and their
assigned diets during the ﬁltered air or CS exposures.
CS exposure system
Mice were exposed to CS for 6 h/day for 3 days (8 am–
2 pm) in chambers as previously described [51]. The
chamber atmosphere was controlled with relative humidity
of 41 ± 7% and temperature 21 ± 1C. The nicotine con-
tent in the chamber during the CS exposure was
5.1 ± 0.4 mg/m
3, carbon monoxide level 14 ± 1.0 ppm,
and total suspended particulate concentration 60 ± 2.5 mg/
m
3. This level of CS exposure could be expected to result in
carboxyhemoglobin (HbCO) levels, of approximately 5%
[23]. Immediately after the last CS or ﬁltered air exposure,
all of the mice were euthanized by injection of beuthanasia
(120 mg/kg body weight, i.p.). Lung parenchymal tissue
was dissected away from extra-parenchymal airways and
blood vessels and stored at -80C until RNA extraction
(within 4 weeks).
GeneChip analysis
A total of 24 mouse genome 430A 2.0 arrays, GeneChips,
(Affymetrix, Santa Clara, CA), 4 GeneChips/group of 4
mice were utilized to obtain mRNA expression data. An
aliquot of total RNA extracted from half-a-lung from each
of the 24 mice was processed for GeneChip analysis as
previously described using Affymetrix protocols [15].
RNA extraction and synthesis of biotin-labeled RNA
Lung tissue (*100 mg) from each mouse was homoge-
nized in 1 mL of Trizol Reagent (Invitrogen, Carlsbad,
CA) and total RNA was extracted and quantiﬁed as
described by the manufacturer. An aliquot (20 lg/8 lLo f
water) of total RNA from each mouse lung from each of
the three dietary groups exposed to either CS or ﬁltered air
was used for cDNA synthesis (ﬁrst-strand and second-
strand cDNA synthesis) followed by cleanup of double-
stranded cDNA and synthesis of biotin-labeled cRNA. The
biotin-labeled cRNA (40 lg) from each lung was used for
fragmentation and hybridization to GeneChips.
The scanned images of hybridized signals were analyzed
with the Affymetrix GeneChip Operating Software (GCOS
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Fig. 1 Plasma and lung CARs levels in air breathing mice fed BC
(0.5 g/kg diet) or LY (0.5 g/kg diet) supplemented diet after 1, 2 and
4 weeks. a Plasma levels of BC and LY increased after 1 week. BC
levels decreased after 2 and 4 weeks but LY levels were maintained
for 4 weeks (n = 4 mice per group). b Lung BC levels (nmol/kg lung
tissue) increased after 1 week and decreased after 2 and 4 weeks and
appear to track the plasma BC levels. Lung LY levels increased after
1 week, and its levels slightly increased after 4 weeks (n = 4 mice
per group) (N.D not detected)
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1231.0). When the P value for detection signal was B0.049
(range of P value 0.0002–0.049), the expression of the
mRNA was classiﬁed as ‘‘present’’ (P). All mRNAs with the
P value for detection C0.05 were considered ‘‘absent’’ (A).
The signal intensities for transcripts classiﬁed as present
ranged from 5to7,000 U. The.cel ﬁles fromeach scan were
imported into dChip analyzer, a web based software pack-
age (http://www.dchip.org/) implementing model-based
expression analysis of oligonucleotide arrays [34]. The
dChip analyzer was used for obtaining statistically signiﬁ-
cant differences (P B 0.05, fold change C2.0, and the
differenceinsignalintensityC100)inthemRNAexpression
between the different treatment groups and for generating
qualitative ‘‘heat-maps’’ of selected functionally related
gene clusters. CAR and CS sensitive genes were further
classiﬁed into functional clusters based on their annotations
and descriptions of their functions in the literature.
Validation of GeneChip data
Many reports [16, 44, 66] have shown that the changes in
the expression of mRNAs selected by the analysis of
hybridization data as described above could be conﬁrmed
by independent analysis such as Northern, qualitative
reverse transcriptase (RT) PCR, quantitative real-time RT-
PCR (qRT-PCR), and in some cases by immunoblot anal-
ysis of the encoded proteins [22, 28]. In this study, selected
differentially expressed genes that were relevant to the
major new ﬁndings reported here were subjected to con-
ﬁrmation analysis by real-time PCR.
Quantitative real-time PCR (qRT-PCR)
An aliquot equivalent to 5 lg of total RNA extracted for
GeneChip analysis was reverse-transcribed to obtain cDNA
in a ﬁnal volume of 20 lL reaction buffer consisting of
oligo dT primer, DTT, dNTPs and Superscript II reverse
transcriptase (Invitrogen, Carlsbad, CA). qRT-PCR method
with SYBR green as ﬂuorescent reporter was used to
quantify the expression of selected genes identiﬁed by
GeneChip assay. All the gene speciﬁc primers (Table 1)
were designed with Primer Express 1.0 software (Applied
Biosystems) using gene speciﬁc template obtained from
Affymetrix probe set IDs. The reaction was carried out in
96-well optical well plate containing 6.25 ng RNA in each
well. The applied RNA quantity was further normalized by
amplifying cDNA samples simultaneously with glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) speciﬁc
primers. The transcript levels were measured by real-time
RT-PCR using ABI PRISM 7700 Sequence detection sys-
tem (PE Applied Biosystems, Foster City, CA). PCR
ampliﬁcation parameters were: initial denaturation step at
95C for 10 min followed by 40 cycles, each at 95C for
15 s (melting), 60C for 1 min (annealing and extension).
The 2
-DDCT method [43] was used to calculate relative
changes in gene expression determined from real-time
quantitative PCR experiments (Applied Biosystems User
Bulletin No.2 (P/N4303859). The threshold cycle, Ct,
which correlates inversely with the target mRNA levels,
was measured as the cycle number at which the SYBR
Green emission increases above a threshold level. Speciﬁc
mRNA transcripts were expressed as fold difference in the
expression of speciﬁc genes in RNA samples from lungs of
mice fed basal diet compared to CAR fed diets or between
CS-exposed and air-exposed lungs fed the assigned diets.
Statistical analysis
Statistical evaluation of the CAR concentrations, qRT-PCR
data, and the effects of CS exposure in the three dietary
groups were done by Student’s t test using the statistical
software GraphPad Prism 4.0. In all comparisons differ-
ences with P B 0.05 were considered as signiﬁcant.
Results are expressed as mean ± SEM, the number of
mice/group (n) and the P value.
Results
Effects of CARs and CS on body weight
After the 2-week diet acclimation period, mice were fed on
their assigned diets for 4 weeks. There were no signiﬁcant
differences in body weight between the groups of mice
Table 1 Primer sequences for real-time RT-PCR
Gene Primer sequence (50–30)
GAPDH Sense-GCAACAGGGTGGTG
Antisense-GGATAGGGCCTCTC
CYP1A1 Sense-CAGATGATAAGGTCATCACGA
Antisense-TTGGGGATATAGAAGCCATTC
S100A8
(calgranulin A)
Sense-GCATCTCACAAAGACAGCCACA
Antisense-AGCCCTAGGCCAGAAGCTCT
S100A9
(calgranlin B)
Sense-GATGGCCAACAAAGCACCTT
Antisense-ATGATGGTGGTTATGCTGCG
Slfn4 Sense-ACAAGTGATGCCTGGAAAGG
Antisense-GACTGCCCTGGGAAATATGA
IL1-beta Sense-CCAAAAGATGAAGGGCTGCT
Antisense-TCATCTGGACAGCCCAGGTC
CBR-3 Sense-TACTTGGCTCTCCTGCCTCC
Antisense-GACTAGCTGGCCGTGAGGTT
The oligonucleotide sequence for each primer was obtained by Primer
Express software using gene speciﬁc sequence from Affymetrix probe
set data base. The primers were custom prepared and used as
described in Sect. ‘‘Methods’’
26 Genes Nutr (2009) 4:23–39
123before CS exposure (Fig. 2). Half of the mice were then
exposed to CS (6 h/day for 3 days) and the remaining half
to ﬁltered air. Air breathing mice on basal or LY-supple-
mented diets gained a small but signiﬁcant amount of
weight after 3 days. All CS-exposed mice showed a small
decrease in body weight which was only statistically sig-
niﬁcant (P B 0.05) in BC fed mice.
CAR concentration
Plasma and lung concentrations of BC and LY in mice fed
the three assigned diets for 4 weeks are shown in Table 2.
Neither of the two CARs were detectable in plasma or
lungs of mice fed the basal AIN-93G diet supplemented
with gelatin beadlets (the carriers of synthetic crystalline
CARs). After 4 weeks of feeding CAR supplemented diets,
large and signiﬁcant (P B 0.001) increases in the plasma
and lung CARs were detected. BC and LY concentrations
in plasma were 50.3 ± 13.7 and 179.8 ± 16.2 nM,
respectively. BC and LY concentrations in lungs were
139.6 ± 11.6 and 308.0 ± 62.4 nmol/kg wet weight of
lung tissue, respectively. The data suggest that the lung
tissue bioavailability of LY may exceed that of BC under
similar basal diet composition and feeding conditions.
However, as an unspeciﬁed amount of BC was probably
converted to vitamin A in gut and/or liver tissue [29]o r
metabolized [24, 82], direct comparisons of overall
absorption kinetics of the two CARs cannot be ascertained.
The concentrations of lung CARs are within the range of
those described for humans [63], the plasma LY concen-
trations being similar to those of 866 men [27].
Bioactivity of CARs: CAR sensitive genes in mice
breathing air
The bioactivity of the two CARs was assessed by evalua-
tion of their effects on the lung transcriptome. High density
oligonucleotide arrays containing 22,600 probe sets (mouse
genome 430 A 2.0) that represent a large fraction of the
mouse expressed genome were used. The total number of
mRNAs detected in the lungs from the air and CS breathing
mice fed the three assigned diets were *15,000 and they
were not signiﬁcantly different from each other in the
various groups of mice. The coefﬁcient of variation of the
total number of expressed genes detected in each group of
3–4 mice was \5%. Differential analysis of gene expres-
sion data showed that the elevated concentrations of CARs
signiﬁcantly affected the expression of a small number of
genes (Table 3) which were a very small fraction (0.09 and
0.02%, respectively), of the *15,000 lung genes that were
reliably detected.
Global gene expression analysis identiﬁed qualitative
and quantitative differences in the lungs response to diet
induced CAR augmentations. Although the lung concen-
tration of BC was lower than that of LY in air breathing
mice, more genes were affected by BC than by LY when
compared to the expression of genes in lungs of mice fed
the basal diet (Tables 3, 4). The expression of cytochrome
P450 1a1 (cyp1a1) was induced by *twofold in the lungs
of the CAR fed mice (Table 4; Fig. 3). The induction of
cyp1a1 by BC and LY in air breathing lungs was also
independently conﬁrmed by qRT-PCR (Fig. 3b). The
GeneChip data also suggest that another transcriptionally
regulated gene that encodes D site albumin binding protein
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Fig. 2 Effects of CARs on body weight in mice breathing air or after
3 days of CS exposure. Air breathing mice on basal or LY-
supplemented diet gained small but signiﬁcant weight. In the CS
breathing groups of mice, only BC fed mice lost small but signiﬁcant
weight after CS exposure. Air air breathing for 3 days, CS 60 mg/m
3
of total suspended particles for 6 h/day for 3 days, n = 4, * P\0.05
Table 2 Mice were fed either the basal diet or diets containing
500 mg/kg of either BC or LY for 4 weeks
Control diet b-carotene diet Lycopene diet
Plasma (nM)
b-carotene \3.7 50.3 ± 13.7
a \3.7
Lycopene \3.7 \3.7 179.9 ± 16.2
a
Lung (nmol/kg)
b-carotene \60 139.6 ± 11.6
a \60
Lycopene \60 \60 308.1 ± 62.5
a
Concentration of BC and LY were measured in plasma (nM) or lung
(nmol/kg) at time of sacriﬁce
a All data are given as mean ± SEM, n = 4. BC and LY were below
the limit of detection in plasma and lung of mice fed the basal diet.
Four weeks of dietary supplementation resulted in a large and sig-
niﬁcant (P\0.001) increase in plasma and lung concentrations of the
two CARs
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123(Dbp) also responds like the cyp1a1 gene in the presence of
BC or LY (Table 4).
Several genes were modulated by BC but not LY
(Table 4). These data suggest that the GeneChip assay can
discriminate between the in vivo actions of the two CARs.
The most noteworthy difference was the induction of the
gene encoding lecithin-retinol acyltransferase (Lrat), which
is a retinol esterifying enzyme. Fig. 4 shows GeneChip
data for the expression of Lrat and a related acyltransferase
to illustrate the speciﬁc induction of Lrat in the lungs of
mice fed only the BC diet. Additional genes whose
induction was similar to that of Lrat included genes
encoding transcription factors such as period 2 (Per2) and
hepatic leukemia factor (Hlf). BC diet supplementation
also up-regulated the expression of aquaporin-3 (Aqp3) and
down-regulated that of sodium channel (Scn8a) genes. Two
genes of unknown functions were repressed by LY but
unaffected by BC.
Cigarette smoke-related effects on lung gene expression
and modiﬁcation by CARs
A large number of genes were modulated in the lungs of
mice breathing CS compared to those breathing ﬁltered air.
The analysis detected a higher number of CS sensitive
genes in the lungs of mice fed both CAR supplemented
diets compared to those of mice fed the CAR deﬁcient,
basal diet. The total number of genes affected was 40, 73,
and 65 in the lungs of mice fed the basal, BC- or LY-
supplemented diets, respectively (Table 3). Many of these
CAR-modulated genes in CS-exposed lungs relate to genes
involved in inﬂammatory-immune functions.
A robust activation of Phase I and Phase II response
detected by the GeneChip assay in the lungs of CS-exposed
mice was expected [14, 50] and further validated the 3-day
(6 h/day) acute CS exposure paradigm and GeneChip
analysis. Fig. 5 illustrates the qualitative relative expres-
sion of a cluster of eight co-regulated genes in the lungs of
mice that were on the three assigned diets and were
allowed to breathe either air or CS. Table 5 shows a robust
expression of Phase I and II response genes as a result of
3 days of CS breathing in the mice fed the three diets. The
CAR diets did not affect CS-induced responses of this
cluster of genes. The induction of this family of genes in
mouse lungs has previously been described [58] and further
validates our GeneChip analysis. A number of genes
encoding transcription factors which were induced by the
BC-supplemented diet in air breathing mice were further
increased after CS exposure. These genes included Dbp,
Per2, Per3, Cry1 and Hlf (Fig. 4; Table 5).
The major novel discovery of this in vivo genome-wide
screen is the identiﬁcation of a large cluster of inﬂamma-
tory-immune genes that are induced by dietary LY but not
BC in the lungs of CS-exposed mice (Fig. 6). Three dis-
tinct clusters of genes could be identiﬁed in this group of
inﬂammatory-immune genes. Cluster I (2 genes) showed
low expression in the lungs of all mice except those that
Table 3 Summary of genome-wide responses of lungs to diets in air
and cigarette smoke (CS) exposed mice
Diet/
treatment
Total number
of genes
affected
% of total
number of
genes affected
Up-r
egulated
Down-
regulated
BC/AIR 13 0.09 11 2
LY/AIR 3 0.02 1 2
Basal/CS 40 0.27 27 13
BC/CS 73 0.49 17 56
LY/CS 65 0.43 54 11
Effects of dietary b-carotene (BC) or lycopene (LY) on gene
expression in the lungs of air breathing mice were obtained by
comparing the entire list of genes from mice fed either BC- or LY-
supplemented diet with that obtained from the lungs of air breathing
mice fed the basal diet. The number differentially expressed, carot-
enoid sensitive genes (column 2) is also shown as the % of the total
number of genes detected in the lungs from either BC- or LY-fed
mice (column 3). CS sensitive genes in each dietary group were
obtained by comparing the entire list of genes detected in the lungs of
CS breathing mice with that expressed in air breathing mice. The total
number of differentially expressed, CS sensitive genes (column 2) is
shown also shown as % of the total genes detected (column 3) in the
lungs of CS breathing mice
Table 4 b-carotene (BC) or lycopene (LY) sensitive genes in lungs
of mice
Diet Name of gene Up-/down-
regulated
BC Cytochrome P450, 1a1; Cyp1a1 Up
D site albumin promoter binding protein, Dbp Up
Period homolog 2 (Drosophila), Per2 Up
Fibroblast growth factor 3, Fgf3 Up
Hepatic leukemia factor, Hlf Up
Immunoglobulin joining chain, Igj Down
Lecithin-retinol acyltransferase, Lrat Up
Aquaporin 3, Aqp3 Up
Sodium channel, voltage-gated, type VIII,
alpha polypeptide, Scn8a
Down
RIKEN cDNA A930004D23 gene Up
Expressed sequence AL033314 Up
RIO kinase 3 (yeast) Up
Unknown gene Up
Unknown gene Up
LY Cytochrome P450, 1a1; Cyp1a1 Up
D site albumin promoter binding protein, Dbp Up
RIKEN cDNA 5730454B08 gene Down
RIKEN cDNA 2210401K01 gene Down
Gene symbols are shown in bold ﬁgures
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123were fed LY-supplemented diet and exposed to CS; these
two genes are frequently used as markers of neutrophils [8,
70]. A large sub-group of 24 genes, cluster II, Fig. 6, was
moderately expressed in the lungs of mice fed the basal diet
or the BC-supplemented diet. The lungs of BC-supple-
mented mice breathing air showed higher expression of this
cluster of genes when compared to that in the lungs of other
groups of mice breathing air. Their expressions were sup-
pressed by exposure to CS. In contrast to the suppressing
effects of CS on these cluster II genes in mice fed the basal
or the BC diet, the LY fed mice showed obvious aug-
mentation of their expression. Inductions of Cal A, Cal B,
Slfn4, IL1b, and carbonyl reductase 3 (Cbr3) genes in CS
breathing lungs of mice fed LY-supplemented diet and
suppression of these genes in the CS breathing lungs of
mice fed BC-supplemented diet were independently con-
ﬁrmed by qRT- PCR (Fig. 7a–c). Genes in cluster III
behave like those in cluster II except that they were highly
expressed in the lungs of air breathing mice fed the basal or
the BC diets.
Discussion
Concentrations of CARS in mouse plasma and lungs
b-carotene and LY supplementations were approximately
equivalent to 125 mg/kg body weight/per day for a human.
A large amount of dietary CARs are necessary in rodents to
obtain increases in tissue CAR concentrations comparable
to levels seen in humans, explained in part by active CAR
cleavage enzyme(s) in the rodent intestine [33]. These high
CAR supplementations were well tolerated by mice as
suggested by the lack of a signiﬁcant decrease in whole
body weights in air breathing CAR supplemented mice
(Fig. 2). Plasma BC concentrations in this study were
*50% of those reported previously in A/J mice fed similar
CAR concentrations [51] and may reﬂect strain speciﬁc
differences in absorption and metabolism of BC or differ-
ences in dietary constituents. In addition, the lipid content
of the rodent diet also appears to be an important con-
tributor to the bioavailability of CARs. This is suggested by
the detection of higher serum BC levels in A/J mice whose
BC-supplemented diets included corn oil (5%) and sodium
cholate (0.25%) [32]. Such modiﬁed rodent diets contain-
ing bile salts and increased vegetable oils have not
systematically been compared with the well characterized
AIN-93G diet optimized for rodent growth and develop-
ment [36]. Plasma and lung concentrations of BC (50 nM
and 140 nmol/kg, lung wet weight, respectively) approxi-
mated levels described for human plasma and lung tissue,
respectively [29, 63].
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Fig. 3 Induction of cytochrome P450 1a1 (cyp1a1) in lungs of mice
fed BC or LY-supplemented diet. a Induction of cyp1a1 detected by
GeneChip analysis, (n = 3–4, * P\0.05 as compared to control);
b induction of cyp1a1 detected by real-time quantitative RT-PCR
(n = 3–4, * P\0.05)
Fig. 4 Selective induction of lecithin-retinol acyl transferase only in
mice fed the BC-supplemented diet. The data obtained from
GeneChip expression analysis show signal intensity for the two acyl
transferases in the lungs of air breathing mice fed the 3 assigned diets
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were lower than those reported in rat serum [66, 81]. The
latter observations suggest signiﬁcant difference between
C57BL/6 mice and F334 rats in the digestion, uptake and/
or metabolism of LY since the basal diets, without added
CARs used in this study were very similar to those that
were used in F344 rats [81]. As for the above-mentioned
case for BC, the lipid composition of the LY-supplemented
diet is likely to affect the serum LY concentration, as
evidenced by the ﬁnding of a higher LY concentration in
the serum of Copenhagen rats compared to F344 rats fed
the AIN-93G diet; the diets of Copenhagen rats were
supplemented with coconut fat (6%w/w) [66].
Bioreactivity of CARs in lungs of air breathing mice
In spite of the somewhat lower concentrations of the two
CARs in mouse lungs compared to those in human and rat
lungs, the two CARs showed signiﬁcant bioactivity, as
determined by the GeneChip assay.
Previous studies have shown the induction of cypla1 by
CARs [30]. The present study also detected the induction
of cypla1 (Fig. 3). A twofold increase in the activity of
cyp1a1 gene in mouse lungs by CAR concentrations that
were lower than those described in previous studies in mice
or in human lungs suggests that the mouse lung genome is
sensitive to dietary CARs and further validates that the
C57BL/6 mouse offers a useful in vivo model to study
CAR metabolism [30]. The cyp1a1 gene encodes a trans-
criptionally regulated enzyme important in the metabolism
of carcinogens [31]. It is driven by the aromatic hydro-
carbon receptor (AhR), a ligand activated transcription
factor of the nuclear receptor superfamily [74]. The role of
AhR in normal physiology remains unclear, but appears to
relate to both environmental pollutants and numerous host
responses including inﬂammation [11, 68, 69]. Dietary
factors appear to activate cyp1a1 by AhR pathways [10],
although the role of other members of ligand activated
nuclear receptors such as RARs cannot be excluded [9].
The induction of cyp1a1 activity by dietary BC has
previously been reported in rats [57] and in ferrets [39] and
has been implicated in the carcinogenic effects of BC [21],
although it cannot be assumed that cyplal itself is neces-
sarily procarcinogenic [26, 45].
The expression of Lrat was induced in the lungs of BC
fed mice (Fig 4). Lrat is transcriptionally regulated by
retinol [84] which can be generated from BC but not LY.
Lrat plays a major role in the metabolism and storage of
vitamin A in different cell types including epithelial cells.
BC is a precursor of vitamin A which is oxidized to retinoic
acid, a known diet derived factor for the regulation of lung
growth and development [79], and regulation of surfactant
proteins in lung type II cell [3, 80]. The basal expression of
Lrat in mouse lungs is similar to that in the liver [42]. Our
GeneChip data suggest that the Lrat gene is further acti-
vated by diet induced augmentation of lung BC.
The gene encoding Dbp (D site albumin promoter
binding protein), a transcription factor implicated in the
regulation of circadian rhythm [53] was seen to be induced
by CARs. Dbp is the founding member of the PAR family
of basic leucine zipper (bZip) transcription factors [48] and
the gene encoding Hlf (hepatic leukemia factor), another
member of the same family [25], was also seen to be up-
regulated by CAR supplementation. Dbp and Hlf were
reported to be sensitive to xenobiotics and stimulate tran-
scription of genes against xenobiotics and oxidative stress
and hence might play a role in modulating the toxicity of
such compounds [13]. Modulation of members of ion- and
water-channel genes by dietary BC and not LY is another
novel ﬁnding in this study and warrants further character-
ization. BC fed mice showed increased expression of Aqp3
gene encoding, a water channel which has been shown to
be regulated by growth factors, inﬂammation, and osmotic
stress [4].
GeneChip data from this in vivo study, focused on
lungs, are also noteworthy for the lack of induction of
Phase II genes by CARs in air breathing mice which may in
part be due to lower CAR levels in lung tissues compared
to levels used in in vitro studies or the dramatic difference
in extracellular milieu between the in vivo and in vitro
Fig. 5 ‘‘Heat-map’’ of cyp1a1-
like cluster of 8 genes. Each
column represents a mouse.
Each row represents a gene.
Lighter color shows low
expression and darker color
shows high expression of the
gene. The expression of the 8
genes was low in the lungs of air
breathing mice but was high in
the lungs of CS breathing mice
30 Genes Nutr (2009) 4:23–39
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123experimental conditions [2]. CAR-dependent induction of
Phase II response has been shown in various cell lines of
liver and intestinal origins [64], and absence of this
response in lungs in vivo may be attributed to differences
in cellular origins and assay conditions including intracel-
lular concentrations of the CARs and their metabolites.
Some of the Phase II response genes are driven by the
redox sensitive transcription factor Nrf2 which binds to
antioxidant response elements (ARE) and up-regulates
protective detoxifying enzymes related to oxidative stress
[49]. BC and LY are singlet oxygen scavengers; therefore,
lack of any modulation of ‘‘classical’’ antioxidant response
genes such as heme-oxygenase 1 (HO-1), superoxide dis-
mutases (Sod) and glutamate-cysteine ligase (Gclc) is also
Fig. 6 ‘‘Heat-map’’
inﬂammation-immune related
genes in the lungs of mice fed
the 3 assigned diets. Each
column represents a mouse and
each row a gene. Three distinct
patterns of expression could be
identiﬁed. Cluster I shows high
expression only in the CS-
exposed lungs of LY fed mice.
Cluster II shows medium-
expression of genes in air
breathing, BC fed mice and the
expression was suppressed by
CS. The expression of the same
cluster of genes was low in air
breathing mice fed LY but was
induced when the mice were
exposed to CS. Cluster III
shows similar expression in
mice fed the basal or the BC-
supplemented diet but the
expression is reversed in the
mice fed the LY-supplemented
diet
Microarray
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Fig. 7 a Conﬁrmation of
selected inﬂammatory genes by
real-time quantitative RT-PCR.
Suppression of Cal A, Cal B,
slfn 4, gene expression in
BC ? CS-exposed group. b
Induction of Cal A, Cal B, slfn
4, gene expression in LY ? CS-
exposed group. c Induction of
IL1b and Cbr3 gene expression
in LY ? CS-exposed group
(n = 4)
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123noted. We also noted a lack of induction in the expression
of HO-1, Sod and Gclc in the lungs of mice with severe a-
tocopherol deﬁciency imposed either by dietary depletion
or by the deletion of the a-tocopherol transfer protein gene
[17, 55].
Modulation of CS-induced transcriptomes by CARs
A large induction of cyp1a1 gene identiﬁed by the Gene-
Chip assay in the CS-exposed lungs has previously been
demonstrated [14, 39, 71]. As discussed above, the
induction of Cyp1a1 is driven by AhR and the encoded
protein is expressed in airway epithelia and lung paren-
chyma [77]. In the present experiments both CARs induced
cyp1a1 in the lungs of air breathing mice; however, neither
of them affected CS-caused induction of cyp1a1.
The genes of Phase II response encode detoxiﬁcation
and antioxidant enzymes which are induced by CS and
their expression was unaffected by dietary CARs. The
redox sensitive transcription factor, Nrf2, plays an impor-
tant role in the expression of these genes [4, 58]. The co-
ordinated induction of all but Hlf in this cluster of genes is
noteworthy, because they are all associated with the reg-
ulation of circadian rhythm and are expressed in lung cells
[5, 12, 59, 62]. Dbp, Per2 and Hlf are the members of the
proline and acidic amino acid-rich basic leucine zipper
(PAR bZIP) transcription factor family. The suggestion
that this cluster of genes may regulate the cell cycle and
cell proliferation [6] raises the possibility that dietary
CARs and CS interactions may affect cellular homeostasis
through their actions on major regulators of the circadian
rhythm. In contrast to the effects of CS on the ‘‘clock-
genes’’, the expressions of several immune-response genes
such as Spon2, Eln, Igh-6 and Igh-j558 were down-regu-
lated in the CS-exposed lungs of mice fed the BC-
supplemented diet. The functional implications of the
reciprocal relationship between the ‘‘clock-genes’’ that
may affect cell cycle, and immune related genes in
response to dietary CARs and CS remains to be explored.
Carotenoid modulate immune-inﬂammation related
genes in CS-exposed lungs
The major novel discovery of this in vivo genome-wide
screen is the identiﬁcation of a large cluster of inﬂamma-
tory-immune genes that are induced by dietary LY but not
by BC in the lungs of CS-exposed mice (Fig. 6). Review of
the literature suggests that some of the immune-inﬂam-
matory genes, for example, calgranulins A and B, also
designated calprotectins or S100 A8 and A9, and matrix
metalloproteinase 8 and 9 are co-expressed in granulocytes
(derived from myeloid cells). Hence, it is possible that
dietary CARs affect homeostasis of lung speciﬁc
granulocyte population in mice challenged with CS. A
large induction of calgranulins by CS in LY fed mice is
suggestive of an increased recruitment of circulatory
phagocytes to the lung, possible via activation of AhR [68],
although discordant data exist [69]. Cal B is suggested to
be a chemotactic factor for leukocytes [20] and increased
expression of these genes in lung tissues may further
recruit circulating leukocytes to respiratory epithelium,
propagating a cycle of granulocyte transmigration to the
lung. In addition, members of calgranulin family may also
be ligands for receptor for advanced glycation end products
(RAGE) [67]. RAGE is abundantly expressed in mouse
lungs [15] and its activation by ligands such as calgranulins
is suspected to activate molecular signaling pathways that
culminate in mitogenesis, growth inhibition, and apoptosis
[67]. The expression of MMP 8 and MMP 9 which are
produced by macrophages, were also increased in lungs of
LY fed mice exposed to CS. Macrophage proliferation and
activation are implicated in various types of pulmonary
pathology. One important process associated with pul-
monary ﬁbrosis is injury to basement membranes by MMPs
[72]. Expression of MMPs induced by CS exposure may
play a role in the pathogenesis of COPD [78].
A recent study has addressed the effects of BC supple-
mentation and 2-week CS exposure on transcriptomic
responses of lungs in A/J mice [32]. The A/J mouse strain,
in contrast to C57BL/6 used in our study, is susceptible to
spontaneous age-related lung tumors. Furthermore, the
tumor multiplicity of these mice is augmented during the
recovery-phase after chronic ([6 month) exposure to CS
[76]. Although there appears to be a robust Nrf2 driven
response to CS in both the strains of mice, BC-supple-
mentations appear to suggest different transcriptomic
responses in the two strains of mice. We suggest that these
differences are primarily attributed to the differences in the
lung transcriptomes due to distinct genetic backgrounds of
these two strains of mice. Our preliminary data suggest that
*2,000 genes are differentially expressed between the A/J
and C57BL/6 mice, and many of the differentially
expressed genes belong to inﬂammatory gene class.
Additional variables such as the mode of CS exposure
whole-body (our study) versus nose only [32], the exposure
chamber concentration of CS of 60 mg/m
3 (in our study) vs
141.2 mg/m
3 [32] and the duration of exposure, 6 h/day for
3 days (our study) versus 4 h/day, 5 days/week for the ﬁrst
week and 7 days/week the second week [32] are likely to
contribute differences in the BC-induced changes in CS-
related lung gene expressions.
Pathobiologic implications and limitations
How relevant are these ﬁndings for humans? The studies
described here are acute studies and thus represents only a
36 Genes Nutr (2009) 4:23–39
123‘‘snap-shot’’ of genomic responses of lungs to dietary
CAR supplements and their interactions with genomic
responses of lungs to short-term CS exposure. A single
dose of CAR and a single time interval of CS exposure
were used to obtain the present data. The CAR intake and
CS exposures were based on previous studies in mice [51,
75]. The study supports the concept that CAR supplements
are capable of modulating lung gene expression and even
more interestingly, modulate the effects of CS, and might
be expected to modulate lung responses to other inhaled
environmental toxicants. Although C57BL/6 mice are not
the optimal strain for the study of CS-induced lung car-
cinogenesis [76], they offer the advantage of genetic
manipulation to insert or delete genes implicated in human
lung disease related to environmental toxins and dietary
factors formulated to design and test chemopreventive
strategies. The present studies were not designed to spe-
ciﬁcally focus on CAR modulations of CS-related lung
carcinogenic processes.
Some limitations have to be considered; the effects of
CARs and CS on lung speciﬁc cellular constituencies were
not addressed. There is considerable heterogeneity in the
cellular composition and response of different compart-
ments of respiratory tract tissues to environmental
pollutants, as exempliﬁed by cell AhR system responses
[11]. The CAR formulations used in the present study were
similar to those described in a recently published human
study [83]. It should be recognized that considerable dif-
ferential susceptibilities to oxidant stimuli (such as that
posed by CS) exist between different mouse strains [7, 76].
Lastly, it is highly possible that some of the observed
changes in gene proﬁles are produced by the actions of
non-enzymatic and enzymatically generated metabolites of
the ingested CARs, including their metabolic and oxidative
products. These CAR metabolic species were not measured
in the present study, but are known to possess signiﬁcant
bioactivities [24, 65] and need to be addressed in future
studies.
We conclude that C57BL/6 mice offer a viable in vivo
model to study bioavailability and bioactivity of synthetic
and natural CARs and their possible role in modulating
environmentally induced lung pathobiologies. As there is
substantial evidence that dietary supplementations are
capable of modifying biologic responses to air pollutants
[60], and as the C57BL/6 mouse has been genetically
engineered to manipulate multiple pathways related to both
air pollution and diet-related transcriptionally-related
pathways, this mouse model should prove useful for the
interrogation of key pathways of environment-nutrient
interactions in lung tissues.
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